Real-time analysis of liposomal trafficking in tumor-bearing mice by use of positron emission tomography  by Oku, Naoto et al.
(:; :', " '  i:f 
ELSEVIER Biochimica et Biophysica Acta 1238 (1995) 86-90 
BB Biochi~ic~a 
et Biophysica AEta 
Rapid Report 
Real-time analysis of liposomal trafficking in tumor-bearing mice by use 
of positron emission tomography 
Naoto Oku a,,, Yoshihiro Tokudome a, Hideo Tsukada b, Shoji Okada a 
~ Department of Radiobiochemistry, School of Pharmaceutical Sciences, University ofShizuoka, Yada, Shizuoka 422, Japan 
b Center Research Laborato~, Hamamatsu Photonics and Subfemtomole Biorecognition Project, Research Development Corporation of Japan, Hamakita, 
Shizuoka, Japan 
Received 6 February 1995; revised 29 March 1995; accepted 29 March 1995 
Abstract 
Long-circulating liposomes are known to accumulate passively in tumor tissues of tumor-bearing animals. To evaluate the in vivo 
behavior of such liposomes, we investigated the real-time liposomal trafficking by a non-invasive method using positron emission 
tomography (PET). Liposomes composed of dipalmitoylphosphatidylcholine, cholesterol, and palmityl-D-glucuronide (PGlcUA) in a 
molar atio of 4:4:1 were prepared in the presence of 2-[ 18 F]fluoro-2-deoxyglucose ([2-18 F]FDG). [2-18 F]FDG-labeled liposomes ized by 
extrusion through a filter with various-sized pores were administered tomice bearing Meth A sarcoma, and a PET scan was performed for 
120 min. Small-sized, long-circulating liposomes (100 nm in diameter) constructed with PGlcUA tended to accumulate in the tumor 
tissues. On the contrary, control liposomes (100 nm in diameter) containing dipalmitoylphosphatidylglycerol instead of PGlcUA 
accumulated in the liver. Large-sized PGlcUA-containing liposomes (> 300 nm) also accumulated in the liver, as well as in the spleen. 
Time-activity curves indicated that the small long-circulating liposomes ( < 200 nm) transiently accumulated in the liver right after the 
injection but that the accumulation there decreased time-dependently. These data suggest hat, although the majority of small 
long-circulating liposomes remain in the bloodstream, some extravasate once into the interstitial spaces in the liver re-enter the 
bloodstream again, and finally accumulate in the tumor tissues. This PET technique might be useful for studying real-time liposomal 
trafficking and for tumor imaging. 
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Liposomes can be used as ideal drug carriers, especially 
for anticancer agents, since they can encapsulate and de- 
liver large amounts of agents to the target organs, and can 
reduce the rapid excretion of these agents 1 [1-4]. Conven- 
tional liposomes, however, have a limitation for cancer 
therapy, since they tend to be trapped by the reticuloendo- 
thelial system (RES) such as in the liver. Recently it was 
shown that reduced RES uptake was achieved by the 
modification of liposomes with monosialoganglioside GM 1 
[5,6] or polyethyleneglycol (PEG) [7-11], although GMI 
modification was revealed to be effective only in mice and 
not in rats [12] or rabbits [13]. 
These long-circulating liposomes howed further advan- 
tage for cancer therapy due to passive accumulation in 
tumor tissues, since the vasculature in the tumor tissues is 
leaky enough for extravasation of small-sized liposomes. 
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We previously reported that the liposomes modified with a 
glucuronic acid derivative, palmityl-D-glucuronide 
(PGlcUA), had a longer circulation time in the blood- 
stream of rats [14] and mice [15] than conventional lipo- 
somes containing DPPG, and accumulated in the tumor 
tissue of tumor-bearing mice [15]. In this present study 
utilizing positron emission tomography (PET), we investi- 
gated the real-time biodistribution change of conventional 
and long-circulating liposomes having an encapsulated 
positron emitter. This technique is also applicable for 
tumor imaging. 
Dipalmitoylphosphatidylcholine (DPPC), dipalmitoyl- 
phosphatidylglycerol (DPPG), and palmityl-D-glucuronide 
(PGlcUA) were kindly donated by Dr. Yukihiro Namba at 
Nippon Fine Chemical Co. Cholesterol was purchased 
from Sigma (St. Louis, MO), and reduced Triton X-100 
was from Aldrich. Fetal bovine serum (FBS) was obtained 
from Hazleton. [14 C]FDG was purchased from Amersham. 
Liposomes were prepared as follows: DPPC, choles- 
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terol, and PGlcUA or DPPG (4:4:1, molar ratio) dissolved 
in chloroform were dried under reduced pressure and 
stored in vacuo for at least 1 h. Liposomes were produced 
by hydration of the thin lipid film with 1.0 ml of 0.45 M 
sodium gluconate. This liposomal solution was mixed with 
2.0 ml of [2-ISF]FDG solution and freeze-thawed for three 
cycles using liquid nitrogen to encapsulate he radioactive 
chemical into the liposomes. Then the liposomes were 
extruded three times through a polycarbonate membrane 
filter. Thus obtained sized liposomes were diluted with 
saline, centrifuged at 320000 × g for 20 rain in order to 
remove the untrapped [2-18 F]FDG, and resuspended in 
saline. The encapsulation efficiency was 10-15%, depend- 
ing on the liposomal sizes. 
PET analysis of liposomal trafficking in tumor-bearing 
mice was performed as follows: Seven-week-old Balb/c 
male mice (Japan SLC Inc.) were subcutaneously inocu- 
lated into the right posterior flank with 10 6 Meth A 
sarcoma cells. Seventeen days after tumor implantation, 
the mice weighing 25-30 g were anesthetized with sodium 
pentobarbital nd injected into a tail vein with positron- 
labeled liposomes. Tumors having grown for the same 
length of time in mice injected with liposomes were 
weighed and observed to be between 0.6 and 1.9 g. The 
dose was 9 #mol as total lipids, and about 1.85 MBq. The 
emission scan was started immediately after injection and 
performed for 120 min with an animal PET camera 
(Hamamatsu Photonics, HSR-2000) having an effective 
slice aperture of 3.25 mm and resolution of less than 3 mm 
[16]. Scan frame intervals were 2 min during first 60 min 
and 5 min during 60 to 120 min. Before injection of the 
liposomes, transmission scans were obtained by use of an 
18.5 MBq 6SGe/Ga ring source for attenuation correction. 
The radioactivity in the form of coincidence gamma pho- 
tons was measured and converted to Bq/cm 3 of tissue 
volume by calibration after correction for decay and atten- 
uation. A time-activity curve was obtained from the mean 
pixel radioactivity in the region of interest (ROI) of the 
PET images. The result of the PET experiment presented 
in this paper is a typical one obtained from a single scan, 
and similar results were obtained in another epeated ex- 
periment. 
Prior to the PET study, liposomal stability in the serum 
was evaluated by the leakage of [|4C]FDG from lipo- 
somes. Liposomes encapsulating [14C]FDG were prepared 
by the same procedure as used for the preparation of 
[2-18 F]FDG-labeled liposomes. Then the liposomes were 
incubated in PBS or 90% FBS at 37°C, and aliquots were 
collected at specific times and centrifuged. The radioactiv- 
ity in the supematant was measured with a liquid scintilla- 
tion counter (Aloka, LSC3100). Only less than 10% of 
FDG was released from all kinds of liposomes tested after 
a 2-h incubation both in the presence and absence of 
serum, suggesting that the biodistribution of [2-18F]FDG 
reflects that of liposomes in vivo. 
Then the PET analysis of liposomal trafficking was 
performed. Fig. 1 shows the biodistribution of PGlcUA- 
liposomes in an individual mouse. PET images were com- 
posed by the summation of the first 30 min of accumula- 
tion, and corresponding magnetic resonance images taken 
of another mouse similarly settled. The images in the 
figure show the coronal planes ordered from the tail side 
(upper left) to the head side (lower righ0, and indicate the 
positions of the spleen (right side of the images in 4th and 
5th slices), liver (7th and 8th slices), lungs (10th to 12th 
slices) and heart ( l l th slice). Intense accumulation of 
radioactivity shown in the 1 lth slice of PET images indi- 
cates the liposomes in the blood in heart, suggesting the 
high retention of the liposomes in the blood pool. The 
result was confirmed by direct counting of the heart and 
blood radioactivities after killing the animal (data not 
shown). Fig. 2 shows the accumulation of PGIcUA lipo- 
somes of various sizes as well as that of 100-nm conven- 
tional liposomes during the 90 to 120 min period after 
injection of liposomes. Liposomal sizes tested were deter- 
mined by dynamic laser light scattering (Nicomp Model 
370). The observed iameters of 100-nm, 200-nm, 300-nm, 
and 400-nm liposomes were l 11 nm, 198 nm, 280 nm and 
420 nm, respectively. In the case of PGlcUA-liposomes, 
liver and spleen accumulations decreased with decreasing 
liposomal sizes, although splenic accumulation was greater 
compared with the hepatic for all sizes. On the contrary, 
accumulation i the tumor was increased by decreasing the 
sizes, and the highest accumulation was obtained when the 
100-nm PGlcUA-liposomes were injected. Conventional 
liposomes containing DPPG instead of PGlcUA accumu- 
lated intensely in liver, although the size of the liposomes 
was only 100 nm. These data are consistent with previous 
observations that 100-nm PGlcUA-liposomes can avoid 
liver-trapping and accumulate in tumor tissue effectively 
[15]. Accumulation of any kind of liposomes was not 
observed in lungs, heart, kidneys, and the residual tissues 
by PET imaging; i.e., it only occurred in the RES and 
tumor tissues. 
Fig. 3 shows the time-activity curves of liposomal 
accumulation i liver, spleen, and tumor. The trafficking of 
small-sized, long-circulating liposomes of 200 nm or less 
was apparently different from that of larger liposomes. 
Hepatic and splenic accumulation of these liposomes de- 
creased time-dependently. Interestingly, these liposomes 
were found in the liver at a rather high level immediately 
after injection compared with larger liposomes. The initial 
accumulation of these liposomes in the liver might be due 
to extravasation of these liposomes into interstitial spaces 
of the liver; those liposomes would then re-enter the 
bloodstream. Such observation could be obtained only by 
the non-invasive real-time analysis. On the contrary, large 
liposomes of 300 nm or more accumulated in the liver 
time-dependently, suggesting the RES-trapping of these 
liposomes. Splenic uptake of the liposomes was also size- 
dependent, and reached a plateau at approx. 20 min. 
Tumor accumulation was also size dependent, but the 
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Fig. 3. Real-time changes in PGlcUA-liposomal biodistribution deter- 
mined by PET. Time-activity curves of 18F in liver (a), spleen (b), and 
tumor (c) were obtained as described in the text after injection of 100-nm 
(O), 200-nm (za), 300-nm (O), and 400-nm (• )  liposomes. 
critical size might be less than 200 nm, since only the 
100-nm long-circulating liposomes accumulated to become 
2-to 4-fold over the level of the other three sizes of 
liposomes at 2 h after the start of incubation. These results 
indicate the fenestrae of the endothelium in tumor tissues 
are smaller than those of the sinusoidal endothelium in the 
liver. 
Generally, liposomes are recognized and trapped by the 
RES, and suppression of this recognition results in prolon- 
gation of liposomal half-life in the bloodstream. Long-cir- 
culating liposomes tend to accumulate in tumor tissues by 
passive targeting. For tumor imaging and therapy, it is 
preferable that the agents accumulate in the tumor and not 
in other tissues. Thus long-circulating liposomes may pro- 
vide a useful tool for imaging [17,18] and therapy [19-21] 
of tumors. Liu and co-workers investigated the biodistribu- 
tion of another kind of long-circulating liposomes of vari- 
ous sizes, although their method was invasive [22]. They 
also observed that 100-200-nm liposomes were favorable 
for tumor targeting, although smaller liposomes, those less 
than 70 nm, accumulated in the liver. Such smaller vesi- 
cles might be trapped by RES cells, namely, Kupffer cells, 
in the liver, due to decreased long-circulating capability as 
in the case of PEG-liposomes [23]. 
This non-invasive method to determine real-time liposo- 
mal trafficking in vivo is beneficial for obtaining informa- 
tion about liposomal drug disposition, and for preparing 
appropriate formulations of the drug carriers. Furthermore, 
since long-circulating liposomes tend to accumulate in the 
tumor, they might be useful for diagnostic tumor imaging. 
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